FormWeb • medroxyPROGESTERone IM

IHS FormWeb

Approved Formulary

Search by class Show Therapeutic Classes

Staff Telephone Numbers

Webpage Links

Add Formweb to your mobile device

Android iOS

Search results for:

medroxyPROGESTERone IM

medroxyPROGESTERone IM

Brand names: Depo-Provera Contraceptive

Form	Strength
SUSPENSION, INTRAMUSCULAR	150 mg/mL

Display Contraceptives, Progestins Class: 681200, 683200

Medication comments:

USP <800> Hazardous Drug Assessment of Risk (AOR)
Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances. The following outlines must be followed.
generic (Brand) Route [Packaging: Manufacturer ⇒ Dispense]	Activities
medroxyPROGESTERone (Depo-Provera) IM [Vial ⇒ Vial]		Stock @ IDBH? N NIOSH Table 2^B↑
Pharmacy: Receiving / Storage / Preparation Exposure Risk: minimal	• Handling/preparation PPE Requirements: n/a
	• Receiving from Distributor: Standard
	• Pharmacy Storage Area: Carousel
	• Packaging/Reconstitution Location: n/a
	• Compounding (Non-Sterile/Sterile) Location: n/a
	• Omnicell Load: Yes
Transport	• Transport (dose is placed inside a plastic sealable bag): Standard
Nursing: Storage / Administration Exposure Risk: low	• Handling/administration PPE Requirements: Double CX glove, gown. Wash hands after handling
	• Storage of Finished dose in Nursing Area/Procedural Area: Patient Med Drawer Omnicell
	• Signage on Patient Door Required: No
	• Manipulation of Dosage Form: n/a
	• Special Manipulation for Administration: n/a
Disposal / Spills	• Disposal of Drug Waste: Full- black bin Trace/packaging- yellow bin
	• Disposol of Used PPE: yellow bin
	• Spill management: Wear CX gloves; items used to clean up spill should be placed in a sealed bag and put in yellow bin
Reason for exemption of USP<800> Containment Requirements: Purchased in final dosage form for dispensing, product is drawn up by nursing on unit, proper protections in place for administration

Last updated: Jun. 4, 2025

Hazard.Drug Handling(USP 800) USP<800> Hazardous Drug / Assessment of Risk
Black Box Warnings Injection: Loss of Bone Mineral Density
Look-Alike/Sound-Alike medroxyPROGESTERone confused with HYDROXYprogesterone, methylPREDNISolone, methylTESTOSTERone

UpToDate Lexidrug

Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556

This site is intended for the staff of Iredell Health System. While others may view accessible pages, Iredell Health System makes no warranty, express or implied, as to the use of this information outside of Iredell Health System. The content of this policy and procedure document serves as guidance to the delivery of quality patient care. Care providers are expected to exercise critical thinking and situational awareness skills, and in specific situations to take such action as is necessary for the delivery of quality patient care.